fbpx
QQQ
-7.01
283.40
-2.54%
DIA
-1.43
268.07
-0.54%
SPY
-3.39
333.47
-1.03%
TLT
-1.57
160.71
-0.99%
GLD
+ 0.74
174.69
+ 0.42%

MindMed Submits Application To Cross-List At NASDAQ

September 21, 2020 5:01 pm
Share to Linkedin Share to Twitter Share to Facebook Share to Print License More

Psychedelic drug development company MindMed (NEO: MMED) (OTCQB:MMEDF) has submitted an application to cross-list on NASDAQ.

MindMed was the first psychedelics company to go public in March of 2020 on the NEO exchange. The company also lists on the Frankfurt Stock Exchange under the symbol MMQ, and has active operations in Europe through an exclusive research partnership with the Liechti lab at the University Hospital Basel in Switzerland.

MinMed announced the news Monday, just days after Compass Pathways (NASDAQ:CMPS) — a UK-based medicinal psychedelics developer — had become the first psychedelics company to list on a major stock exchange, with an IPO at NASDAQ.

In a recent interview, MindMed Co-CEO JR Rahn told Benzinga that the success of Compass’ IPO is a clear bellwether for the growing psychedelic medicine industry.

“Psychedelics are being seen as a viable potential solution for treating mental health and addiction by Wall Street,” Rahn said.
MindMed is currently researching different psychedelic compounds in order to obtain clinical evidence that allows for the regulation of psychedelics as a way of psychiatric treatment. The company has advanced to its second phase of studies of LSD for the treatment of anxiety, suicide headaches and adult ADHD.

It is also studying MDMA, 18-MC (an ibogaine derivative) and ayahuasca’s active ingredient DMT at phase 1 trials.

Photo by Roberto Júnior on Unsplash


Related Articles

Psyched: Cybin Raises CA$45M, Numinus Harvests Legal Mushrooms, Toadstool Enters Psychedelic Space

Cybin Raises CA$45 Million and Heads Towards NEO Exchange read more

Cannabis Stock Gainers And Losers From October 30, 2020

GAINERS: Golden Leaf Holdings (OTCQB: GLDFF) shares closed up 14.71% at $0.02 read more

IntelGenx And Heritage Cannabis Holdings Partner To Produce CBD Filmstrip Products

IntelGenx Corp. (TSXV: IGX) (OTCQB: IGXT) has partnered with Canadian medical cannabis producer Heritage Cannabis Holdings Corp. to produce filmstrip products containing CBD. read more

Cannabis Movers & Shakers: TILT, Liberty Health, Ikänik Life, PlantEXT, Cann, Organigram

Here is a summary of the latest company shakeups within the cannabis industry. read more

Cannabis Stock Gainers And Losers From October 29, 2020

GAINERS: Vireo Health Intl (OTCQX: VREOF) shares closed up 19.23% at $1.03 read more